1 Market Overview
1.1 Dolutegravir Introduction
1.2 Market Analysis by Type
1.2.1 10mg Tablets
1.2.2 50mg Tablets
1.3 Market Analysis by Applications
1.3.1 Prevent HIV Infection Following Potential Exposure
1.3.2 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ViiV Healthcare (GSK)
2.1.1 Business Overview
2.1.2 Dolutegravir Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 Shanghai Desano Pharmaceuticals
2.2.1 Business Overview
2.2.2 Dolutegravir Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Dolutegravir Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Aurobindo Pharma
2.4.1 Business Overview
2.4.2 Dolutegravir Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 LAURUS Labs
2.5.1 Business Overview
2.5.2 Dolutegravir Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Adcock Ingram Limited
2.6.1 Business Overview
2.6.2 Dolutegravir Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Dolutegravir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Dolutegravir Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Dolutegravir Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dolutegravir Manufacturer Market Share in 2019
3.3.2 Top 6 Dolutegravir Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Dolutegravir Market Analysis by Regions
4.1 Global Dolutegravir Sales, Revenue and Market Share by Regions
4.1.1 Global Dolutegravir Sales and Market Share by Regions (2015-2019)
4.1.2 Global Dolutegravir Revenue and Market Share by Regions (2015-2019)
4.2 North America Dolutegravir Sales and Growth Rate (2015-2019)
4.3 Europe Dolutegravir Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Dolutegravir Sales and Growth Rate (2015-2019)
4.5 South America Dolutegravir Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Dolutegravir Sales and Growth Rate (2015-2019)
5 North America Dolutegravir by Country
5.1 North America Dolutegravir Sales, Revenue and Market Share by Country
5.1.1 North America Dolutegravir Sales and Market Share by Country (2015-2019)
5.1.2 North America Dolutegravir Revenue and Market Share by Country (2015-2019)
5.2 United States Dolutegravir Sales and Growth Rate (2015-2019)
5.3 Canada Dolutegravir Sales and Growth Rate (2015-2019)
5.4 Mexico Dolutegravir Sales and Growth Rate (2015-2019)
6 Europe Dolutegravir by Country
6.1 Europe Dolutegravir Sales, Revenue and Market Share by Country
6.1.1 Europe Dolutegravir Sales and Market Share by Country (2015-2019)
6.1.2 Europe Dolutegravir Revenue and Market Share by Country (2015-2019)
6.2 Germany Dolutegravir Sales and Growth Rate (2015-2019)
6.3 UK Dolutegravir Sales and Growth Rate (2015-2019)
6.4 France Dolutegravir Sales and Growth Rate (2015-2019)
6.5 Russia Dolutegravir Sales and Growth Rate (2015-2019)
6.6 Italy Dolutegravir Sales and Growth Rate (2015-2019)
7 Asia-Pacific Dolutegravir by Country
7.1 Asia-Pacific Dolutegravir Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Dolutegravir Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Dolutegravir Revenue and Market Share by Country (2015-2019)
7.2 China Dolutegravir Sales and Growth Rate (2015-2019)
7.3 Japan Dolutegravir Sales and Growth Rate (2015-2019)
7.4 Korea Dolutegravir Sales and Growth Rate (2015-2019)
7.5 India Dolutegravir Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Dolutegravir Sales and Growth Rate (2015-2019)
8 South America Dolutegravir by Country
8.1 South America Dolutegravir Sales, Revenue and Market Share by Country
8.1.1 South America Dolutegravir Sales and Market Share by Country (2015-2019)
8.1.2 South America Dolutegravir Revenue and Market Share by Country (2015-2019)
8.2 Brazil Dolutegravir Sales and Growth Rate (2015-2019)
8.3 Argentina Dolutegravir Sales and Growth Rate (2015-2019)
8.4 Colombia Dolutegravir Sales and Growth Rate (2015-2019)
9 Middle East and Africa Dolutegravir by Countries
9.1 Middle East and Africa Dolutegravir Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Dolutegravir Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Dolutegravir Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Dolutegravir Sales and Growth Rate (2015-2019)
9.3 Turkey Dolutegravir Sales and Growth Rate (2015-2019)
9.4 Egypt Dolutegravir Sales and Growth Rate (2015-2019)
9.5 Nigeria Dolutegravir Sales and Growth Rate (2015-2019)
9.6 South Africa Dolutegravir Sales and Growth Rate (2015-2019)
10 Global Dolutegravir Market Segment by Type
10.1 Global Dolutegravir Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Dolutegravir Sales and Market Share by Type (2015-2019)
10.1.2 Global Dolutegravir Revenue and Market Share by Type (2015-2019)
10.2 10mg Tablets Sales Growth and Price
10.2.1 Global 10mg Tablets Sales Growth (2015-2019)
10.2.2 Global 10mg Tablets Price (2015-2019)
10.3 50mg Tablets Sales Growth and Price
10.3.1 Global 50mg Tablets Sales Growth (2015-2019)
10.3.2 Global 50mg Tablets Price (2015-2019)
11 Global Dolutegravir Market Segment by Application
11.1 Global Dolutegravir Sales Market Share by Application (2015-2019)
11.2 Prevent HIV Infection Following Potential Exposure Sales Growth (2015-2019)
11.3 Other Sales Growth (2015-2019)
12 Dolutegravir Market Forecast (2020-2025)
12.1 Global Dolutegravir Sales, Revenue and Growth Rate (2020-2025)
12.2 Dolutegravir Market Forecast by Regions (2020-2025)
12.2.1 North America Dolutegravir Market Forecast (2020-2025)
12.2.2 Europe Dolutegravir Market Forecast (2020-2025)
12.2.3 Asia-Pacific Dolutegravir Market Forecast (2020-2025)
12.2.4 South America Dolutegravir Market Forecast (2020-2025)
12.2.5 Middle East and Africa Dolutegravir Market Forecast (2020-2025)
12.3 Dolutegravir Market Forecast by Type (2020-2025)
12.3.1 Global Dolutegravir Sales Forecast by Type (2020-2025)
12.3.2 Global Dolutegravir Market Share Forecast by Type (2020-2025)
12.4 Dolutegravir Market Forecast by Application (2020-2025)
12.4.1 Global Dolutegravir Sales Forecast by Application (2020-2025)
12.4.2 Global Dolutegravir Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
